Found: 7
Select item for more details and to access through your institution.
Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37030-w
- By:
- Publication type:
- Article
Bortezomib in previously treated phosphatase and tension homology‐deficient patients with advanced intrahepatic cholangiocarcinoma: An open‐label, prospective and single‐centre phase II trial.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 5, p. 1, doi. 10.1002/ctm2.1675
- By:
- Publication type:
- Article
Treatment of multicentric Castleman's Disease accompanying multiple myeloma with bortezomib: a case report.
- Published in:
- Journal of Hematology & Oncology, 2009, v. 2, p. 1, doi. 10.1186/1756-8722-2-19
- By:
- Publication type:
- Article
The pattern of tumor progression on first-line immune checkpoint inhibitor-based systemic therapy for Chinese advanced hepatocellular carcinoma -- CLEAP 004 study.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1310239
- By:
- Publication type:
- Article
PTEN deficiency facilitates gemcitabine efficacy in cancer by modulating the phosphorylation of PP2Ac and DCK.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 704, p. 1, doi. 10.1126/scitranslmed.add7464
- By:
- Publication type:
- Article
PTEN status determines chemosensitivity to proteasome inhibition in cholangiocarcinoma.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 562, p. 1, doi. 10.1126/scitranslmed.aay0152
- By:
- Publication type:
- Article
Extramedullary plasmacytoma in the presence of multiple myeloma: clinical correlates and prognostic relevance.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 329, doi. 10.2147/OTT.S35348
- By:
- Publication type:
- Article